Weekly Biotech Update from Market Exclusive Covering - Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), Kempharm Inc. (NASDAQ:KMPH), Pfizer Inc. (NYSE:PFE), Sarepta Therapeutics Inc (NASDAQ:SRPT), Collegium Pharmaceutical Inc. (NASDAQ:COLL),

NEW YORK, NY / ACCESSWIRE / May 2, 2016 / Market Exclusive Weekly Biotech Report including:

- Sarepta Therapeutics (NASDAQ: SRPT)
- Collegium Pharmaceutical inc. (NASDAQ: COLL)
- Acadia Pharmaceuticals Inc. (NASDAQ: ACAD)
- Kempharm Inc (NASDAQ: KMPH)

The Past Week

Monday April 25, 2016 - Friday April 29, 2016

Last week was an historic one for biotech, particularly the drug approval process, FDA power plays and hierarchy and the battle between human mercy and rigid government bureaucracy. This all played out with Sarepta Therapeutics (NASDAQ:SRPT) on April 25th. Read More.

Click Here to access the full report.

SOURCE: Market Exclusive

ReleaseID: 439456

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.